FICKENSCHER JAMES E (Chief Financial Officer) sold 3.4% of their position (6.01K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $6.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/20/2022ACC: 0001062993-22-016556
Officer· Chief Financial Officer
Since Aug 2018
+14.79K
Net shares
Net buyer
$6.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
20.80K acquired · 6.01K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.80K
Price / share
—
Trade value
—
% of position
13.2%
7/18/2022
157.72K→178.52K
Common Stock
Direct
Shares
−6.01K
Price / share
$1.10
Trade value
$6.61K
% of position
3.4%
7/19/2022
178.52K→172.50K
Total
Net shares
+14.79K
Net value
-$6.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/18/2022 | A · Award | +20.80K | — | — | 13.2% | 157.72K | 178.52K |
| Common Stock Direct | 7/19/2022 | S · Sale | −6.01K | $1.10 | $6.61K | 3.4% | 178.52K | 172.50K |
| Total | +14.79K | -$6.61K | ||||||
Derivative Transactions0
No derivative transactions reported